News
-
Scientists Design Nano-Sized Drug Transporter To Fight Disease
7/29/2011
Scientists seeking to improve cancer treatments have created a tiny drug transporter that maximizes its ability to silence damaging genes by finding the equivalent of an expressway into a target cell.
-
Phase III Trial Of Novartis Drug Afinitor Met Primary Endpoint Of Reducing SEGA Tumor Size In Patients With Tuberous Sclerosis
7/15/2011
Novartis announced recently Phase III trial results that showed more than one-third of patients taking Afinitor (everolimus) tablets experienced a 50% or greater reduction in the size of their subependymal giant cell astrocytomas (SEGAs), non-cancerous brain tumors associated with tuberous sclerosis complex (TSC).
-
Adeona Announces Positive Alzheimer's Subgroup Analysis That Supports Additional Clinical Study Of Proprietary Zinc-Based Therapy
6/2/2011
Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today positive findings based on further analyses from the clinical study evaluating reaZin along with near-term plans for its Alzheimer's disease program.
This website uses cookies to ensure you get the best experience on our website. Learn more